Related Experiment Video
Updated: Aug 17, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Prenatal exposure to maternal undernutrition induces adult cardiac dysfunction
Kuljeet K Cheema1, Melissa R Dent, Harjot K Saini
1Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre & Department of Human Nutritional Sciences, Faculty of Human Ecology, University of Manitoba, Winnipeg, Canada R2H 2A6.
Insights
Maternal low-protein diets during pregnancy can cause lasting heart problems in offspring. Fetal exposure to low protein (LP) programs later-life cardiac dysfunction, impacting heart structure and function.
Area of Science:
- Developmental biology
- Cardiovascular science
- Nutritional science
Background:
- Adverse fetal environments can lead to chronic diseases later in life.
- The impact of prenatal nutrition on adult heart failure is not well understood.
Purpose of the Study:
- To investigate the long-term effects of maternal low-protein (LP) diet on offspring cardiac function and structure.
- To elucidate the mechanisms underlying LP diet-induced cardiac dysfunction.
Main Methods:
- A rat model was used, with pregnant dams fed either normal or low-protein diets.
- Cardiac function (ejection fraction, pressures, cardiac output) and structure (ventricular dimensions, wall thickness) were assessed at various life stages.
- Cardiomyocyte apoptosis was evaluated.
Main Results:
- Offspring exposed to LP diet showed depressed ejection fraction and increased cardiomyocyte apoptosis early in life.
- While initial cardiac function recovered, left ventricular internal diameters increased, and wall thickness changed progressively.
- At 40 weeks, despite normal ejection fraction, offspring exhibited elevated LV end-diastolic pressure, reduced cardiac output, and impaired contractility.
Conclusions:
- Maternal low-protein diet during gestation programs offspring for cardiac dysfunction in later life.
- Prenatal nutritional insults can have permanent, detrimental effects on cardiovascular health.
- This study highlights the critical role of maternal nutrition in fetal programming of heart health.
Abstract:
An adverse environmental experience of the growing fetus may lead to permanent changes in the structure and function of organs that may predispose the individual to chronic diseases in later life; however, nothing is known about the occurrence and mechanisms of heart failure. We employed a rat model in which pregnant dams were fed diets containing either 180 g (normal) or 90 g (low) casein/kg for 2 weeks before mating and throughout pregnancy. The ejection fraction (EF) of the pups exposed to the low-protein (LP) diet was severely depressed in the first 2 weeks of life and was associated with an increase in cardiomyocyte apoptosis. This early depressed cardiac function was followed by progressive recovery and normalization of the EF of the offspring in the LP group. The left ventricular (LV) internal diameters were increased between 24 h and 84 d (12 weeks) of age in the LP-exposed group. Although between 3 d and 2 weeks of age the LV wall of the heart in the LP group was thinner, a progressive increase in LV wall thickness was seen. At 40 weeks of age, although the EF was normal, a two-fold elevation in LV end-diastolic pressure, reduced cardiac output, decreased maximum rates of contraction and relaxation, and reduced mean arterial pressure were observed. Our findings demonstrate that exposure of the developing fetus to a maternal LP diet programs cardiac dysfunction in the offspring in later life.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pathophysiology of Cardiac Performance
Heart Failure II: Pathophysiology
